RORA and prostate carcinoma: Therefore, to ascertain whether our findings of cross-regulation of RORα1 and Wnt target genes in the cell culture and in RORα-deficient fibroblasts do in fact corroborate, immunohistochemical staining was performed on the clinical samples of patients with prostate carcinomas.